Cartica Acquisition (CITE) 10-Q 14 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 13, 2023
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-41198
Entity Registrant Name	CARTICA ACQUISITION CORP
Entity Incorporation, State or Country Code	KY
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	1345 Avenue of the Americas, 11th Floor
Entity Address, City or Town	New York
Entity Address State Or Province	NY
Entity Address, Postal Zip Code	10105
City Area Code	+1-202
Local Phone Number	741-3677
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001848437
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Document and Entity Information
Title of 12(b) Security	Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
Trading Symbol	CITEU
Security Exchange Name	NASDAQ
Class A ordinary shares
Document and Entity Information
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	CITE
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		8,964,415
Redeemable warrants
Document and Entity Information
Title of 12(b) Security	Redeemable warrants
Trading Symbol	CITEW
Security Exchange Name	NASDAQ
Class B ordinary shares
Document and Entity Information
Entity Common Stock, Shares Outstanding		1,000,000

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash	$ 21,345	$ 1,081,479
Prepaid expenses	207,534	338,111
Total Current Assets	228,879	1,419,590
Cash and marketable securities held in Trust Account	45,697,836	240,113,631
Total Assets	45,926,715	241,533,221
Current liabilities
Accrued expenses	223,679	103,031
Promissory note - related party	100,000
Total Current Liabilities	323,679	103,031
Warrant liabilities	1,529,000	2,077,000
Deferred underwriting fee payable		8,050,000
Total Liabilities	1,852,679	10,230,031
Commitments and Contingencies (Note 6)
Shareholders' Deficit
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Additional paid-in capital	3,893,240
Accumulated deficit	(5,517,615)	(8,811,016)
Total Shareholders' Deficit	(1,623,800)	(8,810,441)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders' Deficit	45,926,715	241,533,221
Class A ordinary shares
Shareholders' Deficit
Ordinary shares	475
Class A ordinary shares subject to possible redemption
Current liabilities
Class A ordinary shares subject to possible redemption 4,214,415 and 23,000,000 shares at redemption value of $10.84 and $10.44 as of September 30, 2023 and December 31, 2022, respectively	45,697,836	240,113,631
Common Class B
Shareholders' Deficit
Ordinary shares	$ 100	$ 575

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Preferred stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A ordinary shares
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	300,000,000	300,000,000
Common shares, shares issued	8,964,415
Common shares, shares outstanding	8,964,415
Class A ordinary shares subject to possible redemption
Temporary equity par value	$ 10.84	$ 10.44
Temporary equity, shares outstanding	4,214,415	23,000,000
Class A ordinary shares not subject to possible redemption
Common shares, shares issued	4,750,000	0
Common shares, shares outstanding	4,750,000	0
Class B ordinary shares
Common shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common shares, shares authorized	30,000,000	30,000,000
Common shares, shares issued	1,000,000	5,750,000
Common shares, shares outstanding	1,000,000	5,750,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Operating and formation costs	$ 261,062	$ 437,753	$ 1,411,359	$ 1,807,183
Loss from operations	(261,062)	(437,753)	(1,411,359)	(1,807,183)
Other income:
Interest earned on cash and marketable securities held in Trust Account	1,028,410	1,389,326	6,502,003	1,660,883
Change in fair value of warrant liabilities		(981,000)	548,000	9,546,000
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs			214,220
Transaction costs incurred in connection with the IPO				(378,343)
Other income, net	1,028,410	408,326	7,264,223	10,828,540
Net income (loss)	$ 767,348	$ (29,427)	$ 5,852,864	$ 9,021,357
Class A ordinary shares
Other income:
Basic weighted average shares outstanding		23,000,000		22,410,256
Diluted weighted average shares outstanding		23,000,000		22,410,256
Basic net income per share		$ 0		$ 0.32
Diluted net income per share		$ 0		$ 0.32
Class A ordinary shares subject to possible redemption
Other income:
Basic weighted average shares outstanding	12,435,664	23,000,000	19,457,257	22,410,256
Diluted weighted average shares outstanding	12,435,664	23,000,000	19,457,257	22,410,256
Basic net income per share	$ 0.06		$ 0.25	$ 0.32
Diluted net income per share	$ 0.06		$ 0.25	$ 0.32
Class B ordinary shares
Other income:
Basic weighted average shares outstanding	1,000,000	5,750,000	4,131,868	5,730,769
Diluted weighted average shares outstanding	1,000,000	5,750,000	4,131,868	5,730,769
Basic net income per share	$ 0.06	$ 0	$ 0.25	$ 0.32
Diluted net income per share	$ 0.06	$ 0	$ 0.25	$ 0.32

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT (UNAUDITED) - USD ($)	Class A ordinary shares not subject to possible redemption Ordinary Shares	Common Class B Ordinary Shares	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2021	$ 0	$ 575	$ 24,425	$ (268,389)	$ (243,389)
Balance at the beginning (in shares) at Dec. 31, 2021	0	5,750,000
Increase (Decrease) in Stockholders' Equity
Contribution in excess of fair value of Private Placement Warrants			7,791,000		7,791,000
Remeasurement of Class A ordinary shares to redemption amount			(7,815,425)	(17,893,362)	(25,708,787)
Net income				6,650,368	6,650,368
Balance at the end at Mar. 31, 2022		$ 575		(11,511,383)	(11,510,808)
Balance at the end (in shares) at Mar. 31, 2022		5,750,000
Balance at the beginning at Dec. 31, 2021	$ 0	$ 575	24,425	(268,389)	(243,389)
Balance at the beginning (in shares) at Dec. 31, 2021	0	5,750,000
Increase (Decrease) in Stockholders' Equity
Net income					9,021,357
Balance at the end at Sep. 30, 2022		$ 575		(10,774,233)	(10,773,658)
Balance at the end (in shares) at Sep. 30, 2022		5,750,000
Balance at the beginning at Dec. 31, 2021	$ 0	$ 575	24,425	(268,389)	(243,389)
Balance at the beginning (in shares) at Dec. 31, 2021	0	5,750,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount					(28,895,374)
Balance at the end at Dec. 31, 2022	$ 0	$ 575	0	(8,811,016)	(8,810,441)
Balance at the end (in shares) at Dec. 31, 2022	0	5,750,000
Balance at the beginning at Mar. 31, 2022		$ 575		(11,511,383)	(11,510,808)
Balance at the beginning (in shares) at Mar. 31, 2022		5,750,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount				(244,513)	(244,513)
Net income				2,400,416	2,400,416
Balance at the end at Jun. 30, 2022		$ 575		(9,355,480)	(9,354,905)
Balance at the end (in shares) at Jun. 30, 2022		5,750,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount				(1,389,326)	(1,389,326)
Net income				(29,427)	(29,427)
Balance at the end at Sep. 30, 2022		$ 575		(10,774,233)	(10,773,658)
Balance at the end (in shares) at Sep. 30, 2022		5,750,000
Balance at the beginning at Dec. 31, 2022	$ 0	$ 575	0	(8,811,016)	(8,810,441)
Balance at the beginning (in shares) at Dec. 31, 2022	0	5,750,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount				(2,559,463)	(2,559,463)
Net income				2,064,273	2,064,273
Balance at the end at Mar. 31, 2023		$ 575		(9,306,206)	(9,305,631)
Balance at the end (in shares) at Mar. 31, 2023		5,750,000
Balance at the beginning at Dec. 31, 2022	$ 0	$ 575	0	(8,811,016)	(8,810,441)
Balance at the beginning (in shares) at Dec. 31, 2022	0	5,750,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount					(6,502,003)
Net income					5,852,864
Balance at the end at Sep. 30, 2023	$ 475	$ 100	3,893,240	(5,517,615)	(1,623,800)
Balance at the end (in shares) at Sep. 30, 2023	4,750,000	1,000,000
Balance at the beginning at Mar. 31, 2023		$ 575		(9,306,206)	(9,305,631)
Balance at the beginning (in shares) at Mar. 31, 2023		5,750,000
Increase (Decrease) in Stockholders' Equity
Conversion of Class B ordinary shares to Class A Ordinary Shares - Non- redeemable	$ 475	$ (475)
Conversion of Class B ordinary shares to Class A Ordinary Shares - Non- redeemable (in shares)	4,750,000	(4,750,000)
Waiver of deferred underwriting discount			7,835,780		7,835,780
Capital Contribution by Sponsor for issuance of Non-Redemption agreements to Stockholders			158,139		158,139
Stockholder non-redemption agreements			(158,139)		(158,139)
Remeasurement of Class A ordinary shares to redemption amount			(2,914,130)		(2,914,130)
Net income				3,021,243	3,021,243
Balance at the end at Jun. 30, 2023	$ 475	$ 100	4,921,650	(6,284,963)	(1,362,738)
Balance at the end (in shares) at Jun. 30, 2023	4,750,000	1,000,000
Increase (Decrease) in Stockholders' Equity
Remeasurement of Class A ordinary shares to redemption amount			(1,028,410)		(1,028,410)
Net income				767,348	767,348
Balance at the end at Sep. 30, 2023	$ 475	$ 100	$ 3,893,240	$ (5,517,615)	$ (1,623,800)
Balance at the end (in shares) at Sep. 30, 2023	4,750,000	1,000,000

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows from Operating Activities:
Net income	$ 5,852,864	$ 9,021,357
Adjustments to reconcile net income to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(6,502,003)	(1,660,883)
Change in fair value of warrant liabilities	(548,000)	(9,546,000)
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs	(214,220)
Transaction costs incurred in connection with the IPO		378,343
Changes in operating assets and liabilities:
Prepaid expenses, current portion	130,577	(514,469)
Prepaid expenses, non-current portion		(5,446)
Accrued expenses	120,648	(61,856)
Net cash used in operating activities	(1,160,134)	(2,388,954)
Cash Flows from Investing Activities:
Investment of cash in Trust Account		(236,900,000)
Cash withdrawn from Trust Account in connection with redemption	200,917,798
Net cash provided by (used in) investing activities	200,917,798	(236,900,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid		225,400,000
Proceeds from sale of Private Placements Warrants		15,900,000
Proceeds from promissory note - related party	100,000
Redemption of Class A ordinary shares subject to redemption	(200,917,798)
Repayment of promissory note - related party		(244,225)
Payment of other offering costs		(378,095)
Net cash (used in) provided by financing activities	(200,817,798)	240,677,680
Net Change in Cash	(1,060,134)	1,388,726
Cash - Beginning of period	1,081,479	965
Cash - End of period	21,345	1,389,691
Non-cash investing and financing activities:
Offering costs included in accounts payable		11,880
Remeasurement of Class A ordinary shares to redemption amount	6,502,003	27,342,626
Deferred underwriting fee payable		$ 8,050,000
Waived deferred underwriting discount	$ 7,835,780

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
	Sep. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Cartica Acquisition Corp (the “Company”) was incorporated in the Cayman Islands on February 3, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. On January 7, 2022, the Company closed its initial public offering (the “IPO”) and completed the sale of 23,000,000 units (the “Units”), including 3,000,000 Units sold pursuant to the full exercise of the underwriter’s option to purchase additional units to cover over-allotments, each Unit consisting of (i) one Class A ordinary share of the Company, par value $0.0001 per share (collectively, the “Class A ordinary shares”), and (ii) one Simultaneously with the closing of the IPO, the Company completed the private sale of an aggregate of 15,900,000 warrants (the “Private Placement Warrants”) to Cartica Acquisition Partners, LLC (the “Sponsor”) at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $15,900,000. The Private Placement Warrants are identical to the Warrants sold as part of the Units in the IPO, except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company (except as described in the registration statement for the Company’s IPO (the “Registration Statement”)); (ii) may not (and the Class A ordinary shares issuable upon exercise of such warrants may not) be transferred, assigned or sold by the holders thereof until 30 days after the completion of the Company’s Business Combination (subject to certain exceptions described in the Registration Statement); (iii) may be exercised by the holders thereof on a cashless basis; and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended. Transaction costs amounted to $13,295,086 consisting of $12,650,000 of underwriting discount and $645,086 of other offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The rules of the stock exchange that the Company will list its securities on will require that the Company’s Business Combination must be with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to complete a Business Combination successfully. At the closing of the IPO, an amount equal to at least $10.30 per Unit sold in the IPO, including proceeds from the sale of the Private Placement Warrants, were deposited in a trust account (the “Trust Account”), located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting certain conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of (i) the completion of a Business Combination and (ii) Company’s liquidation. However, to mitigate the risk of us being deemed to have been operating as an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act), the Company intends to, on or prior to the 24-month anniversary of the effective date of the registration statement related to the IPO, instruct Continental Stock Transfer & Trust Company, the trustee with respect to the Trust Account, to liquidate the U.S. government treasury obligations or money market funds held in the Trust Account and thereafter to hold all funds in the Trust Account in cash items until the earlier of consummation of its Business Combination or liquidation. The Company will provide the holders of its issued and outstanding Class A ordinary shares sold as part of the units in its IPO (whether they are purchased in such offering or thereafter in the open market) (the “Public Shares”) (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares, upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company. For the avoidance of doubt, the Public Shares exclude the Class A ordinary shares held by the Sponsor after the Conversion, as defined below. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.30 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations), calculated as of two The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote any Founder Shares (as defined in Note 5) and Public Shares held by it in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association will provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. On June 30, 2023, the Company held an extraordinary general meeting in lieu of an annual meeting and approved an extension to the date by which the Company must consummate a Business Combination from July 7, 2023 (which was 18 months from the closing of IPO) to April 7, 2024 (or such earlier date as determined by the board) (the “Combination Period”). If the Company has not consummated a Business Combination within the Combination Period, the Company will redeem 100% of the Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, subject to applicable law and certain conditions. The Sponsor and the Company’s directors and officers have agreed to waive: (i) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with the completion of the Company’s Business Combination and (ii) their redemption rights with respect to any Founder Shares and Public Shares held by them in connection with a shareholder vote to approve an amendment to the Company’s Amended and Restated Memorandum and Articles of Association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its Business Combination or to redeem 100% of the Public Shares if the Company does not complete its Business Combination within the Combination Period or (B) with respect to any other provision relating to shareholders’ rights or pre- Business Combination activity. The Company will have until April 7, 2024 (or such earlier date as determined by the Company’s board) to complete a Business Combination. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than ten On May 23, 2023, the Sponsor entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with the Cartica Investors, LP and Cartica Investors II, LP (together, the “Cartica Funds”) and Namaste Universe Sponsor LLC, a Delaware limited liability company (“Namaste”). Pursuant to the Purchase Agreement, Namaste acquired from the Cartica Funds, certain membership interests in the Sponsor, which combined interests will entitle Namaste to receive, in the aggregate, 3,490,949 Class B ordinary shares, par value $0.0001 per share and 15,900,000 private placement warrants (the transaction, the “Transfer”). In connection with the Transfer, the Company terminated the Forward Purchase Agreement, amended the administrative support agreement (see Note 5), and experienced a change in its board of directors, as more fully described below within these financial statements. In connection with the Transfer, on May 23, 2023, Subramanian Ramadorai, Keki M. Mistry, Farida Khambata, Parul Bhandari, Asif Ramji and Steven J. Quamme resigned as directors of the Company’s board of directors and Steven J. Quamme resigned as interim Chief Executive Officer. Concurrently with the Transfer, holders of the Company’s Class B ordinary shares elected Suresh Guduru, Suresh Singamsetty, Kishore Kondragunta, Rana Gujral, Kyle Ingvald Parent and John F. Levy as directors of the Company’s board of directors (collectively, the “New Directors”). In addition, Kyle Ingvald Parent and Suresh Singamsetty were appointed as Class I directors with a term expiring at the Company’s first annual general meeting; John F. Levy and Kishore Kondragunta were appointed as Class II directors with a term expiring at the second annual general meeting; and Rana Gujral and Suresh Guduru were appointed as Class III directors with a term expiring at the Company’s third annual general meeting. John F. Levy, Rana Gujral and Kyle Invalid Parent have been appointed as members of the Board’s audit committee (the “Audit Committee”) and compensation, nominating and corporate governance committee, with Mr. Levy serving as the Chairman of the Audit Committee and Mr. Gujral serving as the Chairman of the compensation, nominating and corporate governance committee. The Company’s board determined that John F. Levy, Rana Gujral, Kyle Ingvald Parent and Kishore Kondragunta are each an “independent director” as defined in the Nasdaq listing standards and applicable SEC rules. On June 29, 2023, the Company issued an aggregate of 4,750,000 Class A ordinary shares to the Sponsor, upon the conversion (the “Conversion”) of an equal number of the Company’s Class B ordinary shares, par value $0.0001 per share, held by the Sponsor. The Class A ordinary shares issued in connection with the Conversion are subject to the same restrictions as applied to the Class B ordinary shares before the Conversion, including, among other things, certain transfer restrictions, waiver of redemption rights and the obligation to vote in favor of a Business Combination as described in the prospectus for the Company's IPO. On June 30, 2023, the Company held an extraordinary general meeting in lieu of an annual meeting (the “Meeting”) to amend the Company’s amended and restated memorandum and articles of association (the “Charter Amendment”) to extend the date by which the Company has to consummate a Business Combination from July 7, 2023 to April 7, 2024 (or such earlier date as determined by the Company’s board) (the “Extension”). In connection with the Meeting, shareholders holding 18,785,585 Class A ordinary shares exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. Following the redemptions and the Conversion, there are 8,964,415 Class A ordinary shares issued issued The Sponsor and the Company’s directors and officers have agreed to waive their liquidation rights with respect to any Founder Shares (including any Founder Shares that were converted into Class A ordinary shares) if the Company fails to complete a Business Combination within the Combination Period. However, if any such person acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account. In the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per-share value of the assets remaining available for distribution will be less than $10.30 per Unit. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s the independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amounts in the Trust Account to below the lesser of (i) $10.30 per Public Share or (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.30 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s independent registered public accounting firm), prospective target businesses and other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Liquidity and Going Concern As of September 30, 2023, the Company had $21,345 in its operating bank accounts and working capital of $94,800, when accounting for the Company’s ability to use interest income to pay towards tax liabilities, if any. In August 2023, the Company issued a promissory note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000 (the “Second Promissory Note”). As of September 30, 2023, $100,000 was outstanding on the Second Promissory Note and an aggregate of $200,000 may be borrowed under this note. On November 8, 2023, the Company borrorwed an additional $50,000 under the Second Promissory Note. Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, and structuring, negotiating, and consummating the Business Combination. The Company may need to raise further additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s officers, directors and Sponsor may, but are not obligated to, loan the Company funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. The Company has until April 7, 2024 (or such earlier date as determined by the Company’s board) to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by April 7, 2024. If a Business Combination is not consummated by the liquidation date, there will be a mandatory liquidation and subsequent dissolution. Additionally, the Company does not have sufficient liquidity to fund the working capital needs of the Company through April 7, 2024 or through twelve months from the filing of this report. Management of the Company has determined that the liquidity condition through 12 months from the filing of this report and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raise substantial doubt about the Company's ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after April 7, 2024.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents at September 30, 2023 and December 31, 2022. Cash and Marketable Securities Held in Trust Account At September 30, 2023, substantially all of the assets in the Trust Account were held in a money market fund that invests in U.S. Treasury securities. At December 31, 2022, substantially all of the assets in the Trust Account were held in U.S. Treasury securities with a maturity of 185 days or less. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts. Offering Costs Associated with the IPO The Company complies with the requirements of the FASB ASC 340-10-S99-1. Offering costs consist of underwriting fees, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities have been expensed and offering costs associated with the Class A ordinary shares have been charged to temporary equity at the completion of the IPO. The Company incurred offering costs amounting to $13,295,086 as a result of the IPO (consisting of $12,650,000 of underwriting fees and $645,086 of other offering costs). The Company recorded $12,916,743 of offering costs as a reduction of temporary equity in connection with the Class A ordinary shares included in the Units. The Company immediately expensed $378,343 of offering costs in connection with the Public Warrants and Private Placement Warrants that were classified as liabilities. On April 14, 2023, J.P. Morgan Securities LLC (“J.P. Morgan”), the underwriter for the IPO of the Company, terminated its association with the Company and waived any fees and compensation in connection with such association, including its entitlement to the payment of deferred compensation in the amount of $8,050,000 in connection with its role as underwriter in the Company's IPO. As a result, the Company recognized $214,220 of other income on the Company’s condensed statements of operations attributable to the derecognition of deferred underwriting fees allocated to offering costs and $7,835,780 was recorded to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6). Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands or any other taxable jurisdiction. In accordance with federal income tax regulations, income taxes are not levied on the Company, but rather on the individual owners. United States (“U.S.”) taxation would occur on the individual owners if certain tax elections are made by U.S. owners and the Company were treated as a passive foreign investment company. Additionally, U.S. taxation could occur to the Company itself if the Company is engaged in a U.S. trade or business. The Company is not engaged in a U.S. trade or business at this time. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: ● ● ● Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date. Warrant Liabilities The Company accounts for the 27,400,000 warrants issued in connection with the IPO and the concurrent private placement of warrants, consisting of 11,500,000 Public Warrants and 15,900,000 Private Placement Warrants (inclusive of the exercise of the underwriter’s over-allotment option), in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at fair value. This liability will be subject to re-measurement at each balance sheet date, with any change in fair value being recognized in the Company’s statement of operations for the period ended on such date. Each fair value determination will be based upon a valuation obtained from a third-party valuation firm as and when necessary (See Note 8). Class A Ordinary Shares Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the IPO have been issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of Public Shares classified as temporary equity have been allocated proceeds determined in accordance with ASC 470-20. The Public Shares are subject to ASC 480-10-S99 and are currently not redeemable as the redemption is contingent upon the occurrence of the events mentioned above. According to ASC 480-10-S99-15, no subsequent adjustment is needed if it is not probable that the instrument will become redeemable. In connection with the Meeting (see Note 1), shareholders holding 18,785,585 Class A ordinary shares exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. Following the redemptions and the Conversion, there are 8,964,415 Class A ordinary shares issued issued As of September 30, 2023 and December 31, 2022, the amount of Public Shares reflected on the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 230,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (5,865,000) Class A ordinary shares issuance costs ​ (12,916,743) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 28,895,374 Class A ordinary shares subject to possible redemption as of December 31, 2022 ​ ​ 240,113,631 Less: ​ ​ ​ Due to Shareholders for redemption of 18,785,585 Class A ordinary shares subject to possible redemption ​ ​ (200,917,798) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 6,502,003 Class A ordinary shares subject to possible redemption as of September 30, 2023 ​ $ 45,697,836 ​ Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Subsequent measurement of the redeemable Class A ordinary shares are excluded from the income (loss) per ordinary shares as the redemption value approximates fair value. The Company calculates its earnings per share by allocating net income (loss) pro rata to its Class A and Class B ordinary shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (losses) of the Company. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) IPO, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 27,400,000 Class A ordinary shares in the aggregate. As of September 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 710,235 ​ ​ — ​ $ 57,113 ​ $ (23,434) ​ $ (5,993) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 12,435,664 ​ ​ — ​ ​ 1,000,000 ​ ​ 23,000,000 ​ ​ 5,750,000 Basic and diluted net income (loss) per ordinary share ​ $ 0.06 ​ ​ — ​ $ 0.06 ​ $ (0.00) ​ $ (0.00) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income ​ $ 4,827,677 ​ ​ — ​ $ 1,025,187 ​ $ 7,184,206 ​ $ 1,837,151 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 19,457,257 ​ ​ — ​ ​ 4,131,868 ​ ​ 22,410,256 ​ ​ 5,730,769 Basic and diluted net income per ordinary share ​ $ 0.25 ​ ​ — ​ $ 0.25 ​ $ 0.32 ​ $ 0.32 ​ Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also simplifies the diluted earnings per share calculation in certain areas and introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of ASU 2020-06 is not expected to have an impact on the Company’s financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	9 Months Ended
	Sep. 30, 2023
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Public Units Pursuant to the IPO, the Company sold 23,000,000 Units (which included 3,000,000 Units issued pursuant to the full exercise of the over-allotment option) at a purchase price of $10.00 per Unit. Each Unit consists of one Class A ordinary share and one Public Warrants Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any founder shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Business Combination on the date of the consummation of the Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A ordinary shares during the 20-trading day period starting on the trading day prior to the day on which the Company consummates the Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share warrant redemption trigger price described below under “Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share warrant redemption trigger price described below under the caption “Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. The warrants cannot be exercised until 30 days after the completion of the Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless the Class A ordinary shares issuable upon exercise of the warrants have been registered under the Securities Act or a registration statement under the Securities Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit. If the holders exercise their warrants on a cashless basis, they will pay the warrant exercise price by surrendering warrants for the number of Class A ordinary shares equal to (x) the number of Class A ordinary shares underlying the warrants multiplied by the excess of the “fair market value” (as defined in the next sentence) of the Class A ordinary shares over the exercise price of the warrants, divided by (y) the fair market value. The “fair market value” is the average reported closing price of the Class A ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of warrants, as applicable. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants (except for Private Placement Warrants held by the Sponsor or its permitted transferees): ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption (the “ 30 -day redemption period”), provided that prior to such redemption such holders will be able to exercise their warrants according to their usual exercise rights (i.e., on a cash basis); and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30 -trading day period ending three business days before the Company sends the notice of redemption to the warrant holders, and certain additional terms and conditions are met. Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00 Once the warrants become exercisable, the Company may redeem the outstanding warrants: ● in whole and not in part, and only if the Private Placement Warrants are simultaneously redeemed; ● at a price of $0.10 per warrant; ● upon a minimum of 30 days ’ prior written notice of redemption; provided that prior to such redemption holders will not only be able to exercise their warrants according to their usual exercise rights, but also on a cashless basis and receive the number of shares determined based on the redemption date and the “fair market value” (as defined above) of the Class A ordinary shares except as otherwise described in the warrant agreement; and ● if, and only if, the closing price of the Class A ordinary shares equals or exceeds $10.00 per share for any 20 trading days within the 30 -trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders, and certain additional terms and conditions are met. The Company has agreed that as soon as practicable, but in no event later than twenty (20) business days after the closing of the Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a cashless basis in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of public warrants who exercise their warrants to do so on a cashless basis in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended
	Sep. 30, 2023
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT The Sponsor purchased 15,900,000 Private Placement Warrants (which included 1,500,000 Private Placement Warrants issued pursuant to the full exercise of the over-allotment option) at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $15,900,000 in a private placement that occurred simultaneously with the closing of the IPO. The fair value of a warrant at IPO was $0.51; the aggregate fair value of the proceeds received exceeded the aggregate fair value of the warrants by $7,791,000. This amount was included in other income in the statement of operations during the quarter ended March 31, 2022. Each Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment (see Note 7). A portion of the proceeds from the Private Placement Warrants have been added to the proceeds from the IPO held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Warrants will expire worthless. The Private Placement Warrants are non-redeemable (except as described in Note 3 under “Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00”) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. If they are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants included in the Units being sold in the IPO.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On February 9, 2021, the Company issued 7,187,500 Class B ordinary shares to the Sponsor in consideration for the Sponsor paying certain offering and formation costs on behalf of the Company of $25,000 (the “Founder Shares”). Also on February 9, 2021, the Sponsor granted 1,078,125 Founder Shares, with a total fair value of $3,234, to the Company’s executive officers and consultant. On April 24, 2021, the Sponsor transferred 75,000 Founder Shares to each of its four director nominees at the time (who are now all directors), for a total of 300,000 Founder Shares, with a total fair value of $900, resulting in the Sponsor holding 6,887,500 Founder Shares. On October 29, 2021 the Sponsor granted a director nominee (who is now a director) a membership interest in the Sponsor representing an indirect interest in 75,000 Founder Shares, with a fair value of $225. On October 31, 2021, the Sponsor surrendered 1,437,500 Founder Shares, reducing the total number of Founder Shares outstanding to 5,750,000 Founder Shares (see Note 7). The Founder Shares included an aggregate of up to 750,000 Founder Shares that were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised, so that the total number of Founder Shares would equal 20% of the Company’s issued and outstanding ordinary shares after the IPO. As of January 7, 2022, the over-allotment option was fully exercised, and such shares are no longer subject to forfeiture. The Sponsor and the Company’s directors and executive officers have agreed, subject to limited exceptions, not to transfer, assign or sell any Founder Shares until the earlier to occur of (i) One year after the completion of a Business Combination or (ii) the date following the completion of a Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the shareholders having the right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days On May 23, 2023, the Sponsor entered into the Purchase Agreement with the Cartica Funds and Namaste. Pursuant to the Purchase Agreement, Namaste acquired from the Cartica Funds, certain membership interests in the Sponsor, which combined interests will entitle Namaste to receive, in the aggregate, 3,490,949 Class B ordinary shares, par value $0.0001 per share and 15,900,000 private placement warrants (see Note 1). Promissory Note — Related Party On February 9, 2021, the Company issued a promissory note (the “First Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On September 20, 2021, the Promissory Note was amended to increase the borrowable amount to $350,000 and to extend the maturity date, and on November 15, 2021 to further extend the maturity date. The amended Promissory Note is non-interest bearing and payable on the earlier of (i) March 31, 2022 or (ii) the completion of the IPO. At the consummation of the IPO, the outstanding balance of $244,225 for the First Promissory Note was paid in full by the Company. As of September 30, 2023 and December 31, 2022, no additional amount may be borrowed under this note. In August 2023, the Company issued the Second Promissory Note to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. On September 26, 2023, the Company borrowed $100,000 under the Second Promissory Note. The Second Promissory Note is non-interest bearing and payable on the earlier of: (i) the date of the Company’s liquidation or (ii) the date on which Company consummates its Business Combination. As of September 30, 2023, $100,000 was outstanding on the Second Promissory note and an aggregate of $200,000 may be borrowed under this note. Loans – Related parties In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. The Working Capital Loans would either be repaid upon consummation of a Business Combination or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into warrants of the post- Business Combination entity at a price of $1.00 per warrant. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. As of September 30, 2023 and December 31, 2022, there were no Working Capital Loans outstanding-. Administrative Support Agreement On January 4, 2022, the Company entered into an agreement to pay the Sponsor $930,000 over eighteen months beginning at the closing of the IPO, for the following administrative support expenses: (i) cash compensation to Mr. Goel, the Company’s Chief Executive Officer, in the form of an annual salary of $312,000 ; (ii) cash compensation to Mr. Coad, the Company’s Chief Operating Officer and Chief Financial Officer, in the form of an annual salary of $200,000; and (iii) $9,000 per month for office space, utilities and research, analytical, secretarial and administrative support, which the Sponsor is expected to source principally from Cartica Management, LLC (“Cartica Management”). In addition, at the closing of the IPO, the Company paid the Sponsor an aggregate amount of $601,167 of which $549,000 represented compensation and bonuses paid to Mr. Goel and Mr. Coad for their services through the closing of the IPO and $51,667 represented a prepayment of administrative support expenses for January 2022, to be amortized over the service period. Upon completion of a Business Combination or the Company’s liquidation, the Company will cease paying these amounts (in the case of the officer compensation, after 30 days’ notice). On May 23, 2023, in connection with the Transfer (see Note 1), the Company and the Sponsor entered into an amendment to the administrative support agreement (the “Amended Administrative Support Agreement”), pursuant to which the Company has ceased to pay the Sponsor for (i) the cash compensation to the Chief Executive Officer in the form of an annual salary of $312,000 and (ii) $9,000 per month for office space, utilities, and research, analytical, secretarial and administrative support. Per the Amended Administrative Support Agreement the Sponsor shall (i) pay to the Company’s Chief Operating Officer and Chief Financial Officer an annual cash salary of $200,000, in substantially equal periodic installments, and bonuses of up to $150,000; and (ii) make available, or cause to be made available, to the Company, at a location mutually agreed by the Parties (or any successor location of Sponsor), office space, utilities, and research, analytical, secretarial and administrative support, as may be reasonably required by the Company. In exchange for these services, the Company shall pay Sponsor $16,666.67 per month with the first payment due on or around May 31, 2023 and continuing monthly thereafter until the termination date as defined in the agreement. For the three and nine months ended September 30, 2023, the Company incurred paid Anchor Investors Cartica Investors, LP and Cartica Investors II, LP, two private funds that are affiliates of Cartica Management purchased an aggregate of 1,980,000, or 9.9%, of the Units in the IPO (excluding the Units issued pursuant to the full exercise of the underwriters’ over-allotment option), at the public offering price of $10.00 per Unit for an aggregate amount of $19,800,000. ​ Non-redemption Agreements On June 16, 2023 and June 26, 2023, the Company entered into certain non-redemption agreements (the “Non-Redemption Agreements”) with unaffiliated institutional investors (the “Holders”) in exchange for the Holders agreeing either not to request redemption, or to reverse any previously submitted redemption demand with respect to an aggregate of 3,850,000 Class A ordinary shares, par value $0.0001 per share held by the Holders, in connection with the Meeting. In consideration of the foregoing agreement, the Company shall issue to the Holders an aggregate of 962,500 Class A ordinary shares (the “New Shares”) substantially concurrently with or immediately after, the closing of a Business Combination. The Holders will be entitled to the same registration rights set forth in that certain Registration and Shareholder Rights Agreement, dated as of January 4, 2022, among Cartica Acquisition Partners, LLC, the Company and the other parties thereto, in respect of all the New Shares held by the Holders. The Company estimated the aggregate fair value of the 962,500 Class A ordinary shares attributable to the non-redeeming shareholders to be $158,139 or $0.1643 per share. The excess of the fair value of the Class A ordinary shares was determined to be an offering cost in accordance with Staff Accounting Bulletin Topic 5A. Accordingly, it was recognized by the Company as a capital contribution by the Sponsor to induce them not to redeem, with a corresponding charge to additional paid-in capital to recognize the fair value of the shares transferred as an offering cost.

COMMITMENTS & CONTINGENCIES

COMMITMENTS & CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
COMMITMENTS & CONTINGENCIES
COMMITMENTS & CONTINGENCIES	NOTE 6. COMMITMENTS & CONTINGENCIES Registration Rights The holders of the Founder Shares, Private Placement Warrants and any warrants that may be issued upon conversion of Working Capital Loans (and any ordinary shares issuable upon the exercise of the Private Placement Warrants or warrants issued upon conversion of the Working Capital Loans and upon conversion of the Founder Shares) will be entitled to registration rights pursuant to a registration rights agreement signed on the effective date of the IPO requiring the Company to register such securities for resale. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the date of the IPO to purchase up to 3,000,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. As of January 7, 2022, the over-allotment was fully exercised. The underwriters received a cash underwriting discount of $0.20 per Unit, or $4,600,000 in the aggregate (which included an additional $600,000 received pursuant to the full exercise of the over-allotment option), which was paid at closing of the IPO. In addition, the underwriters were entitled to a deferred fee of $0.35 per Unit, or $8,050,000 in the aggregate (which included an additional $1,050,000 received pursuant to the full exercise of the over-allotment option). The deferred fee would have been payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On April 14, 2023, J.P. Morgan, the underwriter for the IPO of the Company, terminated its association with the Company and waived any fees and compensation in connection with such association, including its entitlement to the payment of deferred compensation in the amount of $8,050,000 in connection with its role as underwriter in the Company’s IPO. As a result, the Company recognized $214,220 of other income on the Company’s condensed statements of operations attributable to the derecognition of deferred underwriting fees allocated to offering costs in the accompanying condensed statements of operations and $7,835,780 was recorded to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying condensed statements of changes in shareholders’ deficit. Forward Purchase Agreement The Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with the Cartica Funds, pursuant to which the Cartica Funds agreed to subscribe for an aggregate of up to 3,000,000 forward purchase shares for $10.00 per share (the “Forward Purchase Shares”), or up to $30,000,000 in the aggregate, in a private placement to close substantially concurrently with the closing of the Company’s Business Combination, subject to approval at such time by the Cartica Management investment committee. Under the Forward Purchase Agreement, the forward purchase investors (i) must vote any Class A ordinary shares owned by them at the time of any shareholder vote to approve a proposed business combination in favor of such proposed business combination, and (ii) would be entitled to registration rights with respect to the Forward Purchase Shares and any other Class A ordinary shares acquired by the forward purchase investors, including any acquired subsequent to the completion of the Business Combination. The proceeds from the sale of the Forward Purchase Shares may be used as part of the consideration to the sellers in the Company’s Business Combination, expenses in connection with the Company’s Business Combination or for working capital in the post-business combination company. These purchases would be required to be made regardless of whether any Class A ordinary shares are redeemed by the Company’s public shareholders. The Forward Purchase Shares would be issued only in connection with the closing of the Business Combination. On October 13, 2022, the Company was advised by Cartica Management that the Cartica Funds will be liquidated in the first half of 2023 (the “Liquidation”). On March 14, 2023, the Company received a written notice from Cartica Management advising the Company that the investment committee of Cartica Management had determined that it would not approve the purchase of any Forward Purchase Shares and therefore the Cartica Funds would not purchase any of the Forward Purchase Shares in connection with the Business Combination or otherwise. On May 23, 2023, in connection with the Transfer, the Company and Cartica Funds entered into an agreement to terminate the rights and obligations of the Company and the Cartica Funds under Forward Purchase Agreement. As a result, the Company may lack sufficient funds to consummate the Business Combination. Service Provider Agreements From time to time the Company has entered into and may enter into agreements with various services providers and advisors, including investment banks, to help us identify targets, negotiate terms of potential Business Combinations, consummate a Business Combination and/or provide other services. In connection with these agreements, the Company may be required to pay such service providers and advisors fees in connection with their services to the extent that certain conditions, including the closing of a potential Business Combination, are met. If a Business Combination does not occur, the Company would not expect to be required to pay these contingent fees. There can be no assurance that the Company will complete a Business Combination. On June 13, 2023, the Company and the Sponsor entered into an agreement with a service provider whereby upon approval of the Extension, which occurred on June 30, 2023, $100,000 was due and payable to the service provider. In addition, upon the consummation of the Company's Business Combination the service provider will earn and receive an additional $100,000 cash payment from the Company and acquire 50,000 Founder Shares from the Sponsor at $0.003 per share, the original purchase price of such shares. The aggregate fair value of the Founder Shares as of June 30, 2023, the date the shareholders approved the Extension, was $8,215 or $0.1643 per Founder Share. During the nine-month period ended September 30, 2023, the Company recognized $100,000 of fees payable which is included in accrued expenses on the Company’s unaudited condensed balance sheets.

SHAREHOLDERS' DEFICIT

SHAREHOLDERS' DEFICIT	9 Months Ended
	Sep. 30, 2023
SHAREHOLDERS' DEFICIT
SHAREHOLDERS' DEFICIT	NOTE 7. SHAREHOLDERS’ DEFICIT Preference Shares Class A Ordinary Shares no issued outstanding Class B Ordinary Shares Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law; provided that only holders of Class B ordinary shares have the right to vote on the appointment of directors prior to the Company’s Business Combination. The remaining Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the completion of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with a Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 30, 2023
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 8. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at September 30, 2023 and December 31, 2022 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Description ​ Level ​ 2023 2022 Assets: ​ ​ ​ ​ Cash and Marketable securities held in Trust Account 1 ​ $ 45,697,836 ​ $ 240,113,631 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Warrant liabilities – Public Warrants 2 ​ $ 575,000 $ 805,000 Warrant liabilities – Private Placement Warrants ​ 3 ​ ​ 954,000 ​ ​ 1,272,000 ​ Cash and Marketable Securities Held in Trust Account As of September 30, 2023, the investment in the Company’s Trust Account consisted of $0 in cash and $45,697,836 in money market funds that invest in U.S. Treasury Securities. As of December 31, 2022, the investment in the Company's Trust Account consisted of $163 in cash and $240,107,374 in U.S. Treasury Securities. The Company classifies its U.S. Treasury Securities as held-to-maturity in accordance with ASC 320 “Investments — Debt and Equity Securities.” Held-to-maturity treasury securities are recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts. The Company considers all investments with original maturities of more than three months but less than one year to be short-term investments. The carrying value approximates the fair value due to its short-term maturity. The carrying value, excluding gross unrealized holding loss and fair value of held to maturity securities on September 30, 2023 and December 31, 2022 are as follows: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Gross ​ Gross ​ ​ ​ ​ Value/Amortized ​ Unrealized ​ Unrealized ​ ​ As of September 30, 2023 Cost Gains Losses Fair Value Marketable securities held in Trust Account ​ $ 45,697,836 ​ $ — ​ $ — ​ $ 45,697,836 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying Gross Gross ​ ​ ​ Value/Amortized ​ Unrealized ​ Unrealized ​ ​ As of December 31, 2022 Cost Gains Losses ​ Fair Value Marketable securities held in Trust Account $ 240,113,631 ​ $ — $ (6,094) ​ $ 240,107,374 ​ Warrant Liabilities The Public Warrants and the Private Placement Warrants have been accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying condensed balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed statements of operations. The Company used both the Black-Scholes Merton formula and a Monte Carlo simulation model to value the Public Warrants and the Private Placement Warrants at Initial Measurement. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one Class A ordinary share and one As of September 30, 2023 and December 31, 2022, in order to value the Private Placement Warrants, the Company compared the expected fair value of the Public Warrants using a Monte Carlo simulation model to the trading value of the Public Warrants to calculate an estimate of the probability of a successful business combination. The inputs used in the Monte Carlo analysis included expected market volatility, expected risk-free interest rate and expected life of the Public Warrants. The Company estimated the selected market volatility following a successful business combination by considering the five‐year historical volatility of the NASDAQ 100 Tech Sector index. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve for a maturity similar to the expected remaining life of the Public Warrants following a successful business combination. The Company used the contractual five-year life as the expected life of the Public Warrants. The Company compared the estimated fair value of the Public Warrants following a successful business combination to the current trading price of the Public Warrants to calculate an estimate of the probability of a successful business combination. The Company then applied a Black-Scholes formula and the calculated probability of a successful business combination to estimate the fair value of the Private Warrants. The inputs into the Black Scholes model for the Private Warrants at initial measurement were the same as those used in the Public Warrant analysis. The fair value of the Public Warrants on September 30, 2023 and December 31, 2022 was classified as Level 1 due to the use of an observable market quote in an active market. The key inputs into the Monte Carlo simulation model and Black-Scholes Merton formula for the Public and Private Placement Warrants were as follows at initial measurement: ​ ​ ​ ​ ​ ​ ​ January 7, Input ​ 2022 ​ Risk-free interest rate ​ 1.64 % Expected term (years) ​ 6.50 ​ Expected volatility ​ 7.2 % Exercise price ​ $ 11.50 ​ Stock price of Class A ordinary share ​ $ 9.83 ​ ​ The key inputs into the Black-Scholes Merton formula for the Private Placement Warrants were as follows at September 30, 2023 and December 31, 2022: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Input ​ 2023 ​ 2022 ​ Risk-free interest rate ​ 4.60 % ​ 3.99 % Expected term (years) ​ 5.52 ​ ​ 5.51 ​ Expected volatility ​ 32.3 % ​ 25.4 % Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price of Class A ordinary share ​ $ 10.77 ​ $ 10.37 ​ ​ The following table provides a summary of the changes in the fair value of the Company’s Level 3 financial instruments that are measured at fair value on a recurring basis: ​ ​ ​ ​ ​ ​ Private ​ ​ Placement ​ ​ Warrants Fair value at December 31, 2022 ​ $ 1,272,000 Change in fair value ​ ​ — Fair value at March 31, 2023 ​ ​ 1,272,000 Change in fair value ​ ​ (318,000) Fair value at June 30, 2023 ​ ​ 954,000 Change in fair value ​ ​ — Fair value at September 30, 2023 ​ $ 954,000 ​ As of January 7, 2022, Initial Measurement, the fair value of the Private Placement Warrants and Public Warrants was determined to be $0.51 per warrant Transfers to and from Levels 1, 2 and 3 are recognized at the end of the reporting period. Following the detachment of the warrants from Units on February 25, 2022, the Public Warrants were transferred from Level 3 to Level 1. As of September 30, 2023, the fair value of the Private Placement Warrants and Public Warrants was determined to be $0.06 and $0.05 per warrant for aggregate values of $954,000 and $575,000, respectively. As December 31, 2022, the fair value of the Private Placement Warrants and Public Warrants was determined to be $0.08 and $0.07 per warrant for aggregate values of $1,272,000 and $805,000, respectively.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 9. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occur after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than as disclosed within these condensed financial statements, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K as filed with the SEC on March 31, 2023. The interim results for the three and nine months ended September 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly, the actual results could differ significantly from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. The Company has not experienced losses on this account.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents at September 30, 2023 and December 31, 2022.
Cash and Marketable Securities Held in Trust Account	Cash and Marketable Securities Held in Trust Account At September 30, 2023, substantially all of the assets in the Trust Account were held in a money market fund that invests in U.S. Treasury securities. At December 31, 2022, substantially all of the assets in the Trust Account were held in U.S. Treasury securities with a maturity of 185 days or less. The Company classifies its U.S. Treasury and equivalent securities as held-to-maturity in accordance with ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are recorded at amortized cost on the accompanying balance sheets and adjusted for the amortization or accretion of premiums or discounts.
Offering Costs associated with the IPO	Offering Costs Associated with the IPO The Company complies with the requirements of the FASB ASC 340-10-S99-1. Offering costs consist of underwriting fees, legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO. Offering costs are allocated to the separable financial instruments issued in the IPO based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities have been expensed and offering costs associated with the Class A ordinary shares have been charged to temporary equity at the completion of the IPO. The Company incurred offering costs amounting to $13,295,086 as a result of the IPO (consisting of $12,650,000 of underwriting fees and $645,086 of other offering costs). The Company recorded $12,916,743 of offering costs as a reduction of temporary equity in connection with the Class A ordinary shares included in the Units. The Company immediately expensed $378,343 of offering costs in connection with the Public Warrants and Private Placement Warrants that were classified as liabilities. On April 14, 2023, J.P. Morgan Securities LLC (“J.P. Morgan”), the underwriter for the IPO of the Company, terminated its association with the Company and waived any fees and compensation in connection with such association, including its entitlement to the payment of deferred compensation in the amount of $8,050,000 in connection with its role as underwriter in the Company's IPO. As a result, the Company recognized $214,220 of other income on the Company’s condensed statements of operations attributable to the derecognition of deferred underwriting fees allocated to offering costs and $7,835,780 was recorded to additional paid-in capital in relation to the waiver of the deferred underwriting discount in the accompanying financial statements (see Note 6).
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of September 30, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the Government of the Cayman Islands or any other taxable jurisdiction. In accordance with federal income tax regulations, income taxes are not levied on the Company, but rather on the individual owners. United States (“U.S.”) taxation would occur on the individual owners if certain tax elections are made by U.S. owners and the Company were treated as a passive foreign investment company. Additionally, U.S. taxation could occur to the Company itself if the Company is engaged in a U.S. trade or business. The Company is not engaged in a U.S. trade or business at this time.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: ● ● ●
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “Derivatives and Hedging.” Derivative instruments are initially recorded at fair value on the grant date and re-valued at each reporting date, with changes in the fair value reported in the statements of operations. Derivative assets and liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.
Warrant Liabilities	Warrant Liabilities The Company accounts for the 27,400,000 warrants issued in connection with the IPO and the concurrent private placement of warrants, consisting of 11,500,000 Public Warrants and 15,900,000 Private Placement Warrants (inclusive of the exercise of the underwriter’s over-allotment option), in accordance with the guidance contained in ASC 815-40. Such guidance provides that because the warrants do not meet the criteria for equity treatment thereunder, each warrant must be recorded as a liability. Accordingly, the Company has classified each warrant as a liability at fair value. This liability will be subject to re-measurement at each balance sheet date, with any change in fair value being recognized in the Company’s statement of operations for the period ended on such date. Each fair value determination will be based upon a valuation obtained from a third-party valuation firm as and when necessary (See Note 8).
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Public Shares sold as part of the Units in the IPO have been issued with other freestanding instruments (i.e., Public Warrants) and as such, the initial carrying value of Public Shares classified as temporary equity have been allocated proceeds determined in accordance with ASC 470-20. The Public Shares are subject to ASC 480-10-S99 and are currently not redeemable as the redemption is contingent upon the occurrence of the events mentioned above. According to ASC 480-10-S99-15, no subsequent adjustment is needed if it is not probable that the instrument will become redeemable. In connection with the Meeting (see Note 1), shareholders holding 18,785,585 Class A ordinary shares exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. Following the redemptions and the Conversion, there are 8,964,415 Class A ordinary shares issued issued As of September 30, 2023 and December 31, 2022, the amount of Public Shares reflected on the balance sheet are reconciled in the following table: ​ ​ ​ ​ ​ Gross proceeds $ 230,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (5,865,000) Class A ordinary shares issuance costs ​ (12,916,743) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 28,895,374 Class A ordinary shares subject to possible redemption as of December 31, 2022 ​ ​ 240,113,631 Less: ​ ​ ​ Due to Shareholders for redemption of 18,785,585 Class A ordinary shares subject to possible redemption ​ ​ (200,917,798) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 6,502,003 Class A ordinary shares subject to possible redemption as of September 30, 2023 ​ $ 45,697,836
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period. Subsequent measurement of the redeemable Class A ordinary shares are excluded from the income (loss) per ordinary shares as the redemption value approximates fair value. The Company calculates its earnings per share by allocating net income (loss) pro rata to its Class A and Class B ordinary shares. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of ordinary shares share pro rata in the income (losses) of the Company. The calculation of diluted income per share does not consider the effect of the warrants issued in connection with the (i) IPO, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 27,400,000 Class A ordinary shares in the aggregate. As of September 30, 2023, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary share is the same as basic net income (loss) per ordinary share for the periods presented. The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 710,235 ​ ​ — ​ $ 57,113 ​ $ (23,434) ​ $ (5,993) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 12,435,664 ​ ​ — ​ ​ 1,000,000 ​ ​ 23,000,000 ​ ​ 5,750,000 Basic and diluted net income (loss) per ordinary share ​ $ 0.06 ​ ​ — ​ $ 0.06 ​ $ (0.00) ​ $ (0.00) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income ​ $ 4,827,677 ​ ​ — ​ $ 1,025,187 ​ $ 7,184,206 ​ $ 1,837,151 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 19,457,257 ​ ​ — ​ ​ 4,131,868 ​ ​ 22,410,256 ​ ​ 5,730,769 Basic and diluted net income per ordinary share ​ $ 0.25 ​ ​ — ​ $ 0.25 ​ $ 0.32 ​ $ 0.32
Recent accounting pronouncements	Recent Accounting Pronouncements In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also simplifies the diluted earnings per share calculation in certain areas and introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The adoption of ASU 2020-06 is not expected to have an impact on the Company’s financial position, results of operations or cash flows. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of the amount of Public Shares reflected on the balance sheet	​ ​ ​ ​ ​ Gross proceeds $ 230,000,000 Less: ​ Proceeds allocated to Public Warrants ​ (5,865,000) Class A ordinary shares issuance costs ​ (12,916,743) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 28,895,374 Class A ordinary shares subject to possible redemption as of December 31, 2022 ​ ​ 240,113,631 Less: ​ ​ ​ Due to Shareholders for redemption of 18,785,585 Class A ordinary shares subject to possible redemption ​ ​ (200,917,798) Plus: ​ Remeasurement of Class A ordinary shares to redemption amount ​ 6,502,003 Class A ordinary shares subject to possible redemption as of September 30, 2023 ​ $ 45,697,836
Schedule of basic and diluted net income per ordinary share	The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts): ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Three Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income (loss) per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income (loss) ​ $ 710,235 ​ ​ — ​ $ 57,113 ​ $ (23,434) ​ $ (5,993) Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 12,435,664 ​ ​ — ​ ​ 1,000,000 ​ ​ 23,000,000 ​ ​ 5,750,000 Basic and diluted net income (loss) per ordinary share ​ $ 0.06 ​ ​ — ​ $ 0.06 ​ $ (0.00) ​ $ (0.00) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ For the Nine Months Ended September 30, ​ ​ 2023 ​ 2022 ​ ​ Class A ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Redeemable ​ Class B Class A Class B Basic and diluted net income per ordinary share ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Numerator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Allocation of net income ​ $ 4,827,677 ​ ​ — ​ $ 1,025,187 ​ $ 7,184,206 ​ $ 1,837,151 Denominator: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Basic and diluted weighted average ordinary shares outstanding ​ ​ 19,457,257 ​ ​ — ​ ​ 4,131,868 ​ ​ 22,410,256 ​ ​ 5,730,769 Basic and diluted net income per ordinary share ​ $ 0.25 ​ ​ — ​ $ 0.25 ​ $ 0.32 ​ $ 0.32

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 30, 2023
FAIR VALUE MEASUREMENTS
Schedule of assets and liabilities that are measured at fair value on a recurring basis	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Description ​ Level ​ 2023 2022 Assets: ​ ​ ​ ​ Cash and Marketable securities held in Trust Account 1 ​ $ 45,697,836 ​ $ 240,113,631 Liabilities: ​ ​ ​ ​ ​ ​ ​ ​ Warrant liabilities – Public Warrants 2 ​ $ 575,000 $ 805,000 Warrant liabilities – Private Placement Warrants ​ 3 ​ ​ 954,000 ​ ​ 1,272,000
Schedule of gross unrealized holding loss and fair value of held to maturity securities	​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying ​ Gross ​ Gross ​ ​ ​ ​ Value/Amortized ​ Unrealized ​ Unrealized ​ ​ As of September 30, 2023 Cost Gains Losses Fair Value Marketable securities held in Trust Account ​ $ 45,697,836 ​ $ — ​ $ — ​ $ 45,697,836 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Carrying Gross Gross ​ ​ ​ Value/Amortized ​ Unrealized ​ Unrealized ​ ​ As of December 31, 2022 Cost Gains Losses ​ Fair Value Marketable securities held in Trust Account $ 240,113,631 ​ $ — $ (6,094) ​ $ 240,107,374 ​
Schedule of key inputs into the Monte Carlo simulation model and Black-Scholes Merton formula for the Public and Private Placement Warrants	​ ​ ​ ​ ​ ​ ​ January 7, Input ​ 2022 ​ Risk-free interest rate ​ 1.64 % Expected term (years) ​ 6.50 ​ Expected volatility ​ 7.2 % Exercise price ​ $ 11.50 ​ Stock price of Class A ordinary share ​ $ 9.83 ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ September 30, December 31, Input ​ 2023 ​ 2022 ​ Risk-free interest rate ​ 4.60 % ​ 3.99 % Expected term (years) ​ 5.52 ​ ​ 5.51 ​ Expected volatility ​ 32.3 % ​ 25.4 % Exercise price ​ $ 11.50 ​ $ 11.50 ​ Stock price of Class A ordinary share ​ $ 10.77 ​ $ 10.37 ​
Schedule of changes in the fair value of the Company's Level 3 financial instruments	​ ​ ​ ​ ​ ​ Private ​ ​ Placement ​ ​ Warrants Fair value at December 31, 2022 ​ $ 1,272,000 Change in fair value ​ ​ — Fair value at March 31, 2023 ​ ​ 1,272,000 Change in fair value ​ ​ (318,000) Fair value at June 30, 2023 ​ ​ 954,000 Change in fair value ​ ​ — Fair value at September 30, 2023 ​ $ 954,000

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)						9 Months Ended
	Jul. 17, 2023 USD ($) shares	Jun. 29, 2023 $ / shares shares	May 23, 2023 $ / shares shares	Jan. 07, 2022 USD ($) $ / shares shares	Feb. 03, 2021 item	Sep. 30, 2023 USD ($) $ / shares shares	Sep. 30, 2022 USD ($)	Nov. 08, 2023 USD ($)	Sep. 26, 2023 USD ($)	Aug. 31, 2023 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Condition for future Business Combination number of businesses minimum | item					1
Share price | $ / shares						$ 10.30
Proceeds from sale of Private Placements Warrants | $							$ 15,900,000
Condition for future Business Combination use of proceeds percentage						80
Condition for future Business Combination threshold percentage ownership						50
Number of days to redeem public shares after the Business Combination						2 days
Condition for future Business Combination threshold net tangible assets | $						$ 5,000,001
Redemption limit percentage without prior consent						15
Obligation to redeem public shares if entity does not complete a Business Combination (as a percent)						100%
Maximum allowed dissolution expenses | $						$ 100,000
Redemption period upon closure						10 days
Payable to stockholders for redemption | $						$ 200,917,798
Cash | $						21,345					$ 1,081,479
Working capital deficit | $						$ 94,800
Class A ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares in a unit						1
Common shares, par value (in dollars per share) | $ / shares						$ 0.0001					$ 0.0001
Number of shares issuable per warrant				1
Common stock, par value per share | $ / shares						$ 0.0001					0.0001
Number of shares issued upon conversion		4,750,000
Common shares, shares issued						8,964,415
Common shares, shares outstanding						8,964,415
Class B ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Common shares, par value (in dollars per share) | $ / shares		$ 0.0001				$ 0.0001					0.0001
Common stock, par value per share | $ / shares		$ 0.0001				$ 0.0001					$ 0.0001
Common shares, shares issued						1,000,000					5,750,000
Common shares, shares outstanding						1,000,000					5,750,000
Class B ordinary shares | Purchase Agreement | Namaste
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Common shares, par value (in dollars per share) | $ / shares			$ 0.0001
Number of shares to be issued in relating to acquisition of membership interests			3,490,949
Common stock, par value per share | $ / shares			$ 0.0001
Class A ordinary shares subject to redemption
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares held by the shareholders exercised their right to redeem such shares.						18,785,585
Payable to stockholders for redemption | $	$ 200,917,798
Shares redeemed	18,785,585					18,785,585
Aggregate amount paid | $	$ 200,917,798
Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				15,900,000
Price of warrant | $ / shares				$ 1
Private Placement Warrants | Purchase Agreement | Namaste
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of warrants to be issued in relating to acquisition of membership interests			15,900,000
Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				11,500,000
Public Warrants | Class A ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares issuable per warrant						1
Share price | $ / shares						$ 11.50
Initial Public Offering
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				23,000,000
Number of warrants in a unit				0.5
Share price | $ / shares				$ 10		$ 10.30
Gross proceeds from issuance of unit | $				$ 230,000,000
Sale of private placement warrants (in shares)				27,400,000
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial Business Combination				30 days
Transaction costs | $				$ 13,295,086
Underwriting fees | $				12,650,000
Other offering costs | $				$ 645,086
Initial Public Offering | Class A ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares in a unit				1
Common shares, par value (in dollars per share) | $ / shares				$ 0.0001
Number of shares issuable per warrant				1
Purchase price, per unit | $ / shares				$ 11.50
Common stock, par value per share | $ / shares				$ 0.0001
Initial Public Offering | Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				23,000,000
Number of shares in a unit				1
Number of warrants in a unit				0.5
Private Placement | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				15,900,000
Price of warrant | $ / shares				$ 1
Proceeds from sale of Private Placements Warrants | $				$ 15,900,000
Over-allotment option
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				3,000,000
Over-allotment option | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of private placement warrants (in shares)				1,500,000
Over-allotment option | Public Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Sale of units, net of underwriting discounts (in shares)				3,000,000
Purchase price, per unit | $ / shares				$ 10
Sponsor | Class B ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Percentage of interest held on issued and outstanding shares						54%
Sponsor | Second Promissory Note
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Aggregate principal amount | $										$ 300,000
Company borrowed | $						$ 100,000			$ 100,000
Maximum borrowing capacity of related party promissory note | $						$ 200,000		$ 50,000

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)			3 Months Ended	9 Months Ended		12 Months Ended
	Jul. 17, 2023	Apr. 14, 2023	Jun. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Jan. 07, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Common stocks issuance costs						$ 12,916,743
Transaction costs incurred in connection with the IPO					$ 378,343
Deferred compensation		$ 8,050,000				8,050,000
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs		214,220		$ 214,220
Waiver of deferred underwriting discount		$ 7,835,780	$ 7,835,780
Unrecognized tax benefits				0		0
Unrecognized tax benefits accrued for interest and penalties				0		$ 0
Payable to stockholders for redemption				200,917,798
Initial Public Offering
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Transaction costs							$ 13,295,086
Underwriting fees							12,650,000
Other offering costs							$ 645,086
Sale of private placement warrants (in shares)							27,400,000
Private Placement Warrants
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Sale of private placement warrants (in shares)							15,900,000
Public Warrants
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Sale of private placement warrants (in shares)							11,500,000
Class A ordinary shares
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Common stocks issuance costs				$ 12,916,743
Common shares, shares issued				8,964,415
Shares outstanding (in shares)				8,964,415
Anti-dilutive securities attributable to warrants (in shares)				27,400,000
Common Class B
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Common shares, shares issued				1,000,000		5,750,000
Shares outstanding (in shares)				1,000,000		5,750,000
Common Class B | Sponsor
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Percentage of interest held on issued and outstanding shares				54%
Class A ordinary shares subject to possible redemption
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Number of shares held by the shareholders exercised their right to redeem such shares.				18,785,585
Payable to stockholders for redemption	$ 200,917,798
Shares redeemed	18,785,585			18,785,585

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Ordinary shares reconciliation (Details) - USD ($)		3 Months Ended						9 Months Ended	12 Months Ended
	Jul. 17, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2022
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds									$ 230,000,000
Proceeds allocated to Public Warrants									(5,865,000)
Class A ordinary shares issuance costs									(12,916,743)
Remeasurement of Class A ordinary shares to redemption amount		$ 1,028,410	$ 2,914,130	$ 2,559,463	$ 1,389,326	$ 244,513	$ 25,708,787	$ 6,502,003	28,895,374
Due to Shareholders for Redemption of 18,785,585 Class A ordinary shares subject to possible redemption								$ 200,917,798
Class A ordinary shares subject to possible redemption
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Due to Shareholders for Redemption of 18,785,585 Class A ordinary shares subject to possible redemption	$ 200,917,798
Shares redeemed	18,785,585							18,785,585
Class A ordinary shares subject to possible redemption as of December 31, 2022				$ 240,113,631				$ 240,113,631
Class A ordinary shares subject to possible redemption as of June 30, 2023		$ 45,697,836						$ 45,697,836	$ 240,113,631

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Income per Ordinary Share (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Class A ordinary shares
Numerator:
Allocation of net income		$ (23,434)		$ 7,184,206
Denominator:
Basic weighted average ordinary shares outstanding		23,000,000		22,410,256
Diluted weighted average ordinary shares outstanding		23,000,000		22,410,256
Basic net income per ordinary share		$ 0		$ 0.32
Diluted net income per ordinary share		$ 0		$ 0.32
Class A ordinary shares subject to possible redemption
Numerator:
Allocation of net income	$ 710,235		$ 4,827,677
Denominator:
Basic weighted average ordinary shares outstanding	12,435,664	23,000,000	19,457,257	22,410,256
Diluted weighted average ordinary shares outstanding	12,435,664	23,000,000	19,457,257	22,410,256
Basic net income per ordinary share	$ 0.06		$ 0.25	$ 0.32
Diluted net income per ordinary share	$ 0.06		$ 0.25	$ 0.32
Class B ordinary shares
Numerator:
Allocation of net income	$ 57,113	$ (5,993)	$ 1,025,187	$ 1,837,151
Denominator:
Basic weighted average ordinary shares outstanding	1,000,000	5,750,000	4,131,868	5,730,769
Diluted weighted average ordinary shares outstanding	1,000,000	5,750,000	4,131,868	5,730,769
Basic net income per ordinary share	$ 0.06	$ 0	$ 0.25	$ 0.32
Diluted net income per ordinary share	$ 0.06	$ 0	$ 0.25	$ 0.32

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - $ / shares		9 Months Ended
	Jan. 07, 2022	Sep. 30, 2023
INITIAL PUBLIC OFFERING
Share price		$ 10.30
Class A ordinary shares
INITIAL PUBLIC OFFERING
Number of shares in a unit		1
Number of shares issuable per warrant	1
Public Warrants
INITIAL PUBLIC OFFERING
Threshold minimum percentage of gross proceeds on total equity proceeds (as a percent)		60%
Number of trading days on which fair market value of shares is reported		20 days
Exercise market value per unit		$ 9.20
Warrants exercisable term after the completion of a business combination		30 days
Public Warrants expiration term		5 years
Agreed business days after the closing of the initial business combination		20 days
Period of time within which registration statement is expected to become effective		60 days
Public Warrants | Class A ordinary shares
INITIAL PUBLIC OFFERING
Number of shares issuable per warrant		1
Share price		$ 11.50
Minimum threshold written notice period for redemption of public warrants		10 days
Public Warrants | Maximum | Class A ordinary shares
INITIAL PUBLIC OFFERING
Purchase price, per unit		$ 9.20
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | Public Warrants
INITIAL PUBLIC OFFERING
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)		115%
Stock price trigger for redemption of public warrants (in dollars per share)		$ 18
Minimum threshold written notice period for redemption of public warrants		30 days
Redemption price per public warrant (in dollars per share)		$ 0.01
Redemption period		30 days
Threshold number of trading days before sending notice of redemption to warrant holders		3 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 | Public Warrants | Class A ordinary shares
INITIAL PUBLIC OFFERING
Share price		$ 18
Stock price trigger for redemption of public warrants (in dollars per share)		18
Redemption of warrants per share		$ 18
Trading period after business combination used to measure dilution of warrant		20 days
Threshold maximum period for filing registration statement after business combination		30 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 | Public Warrants
INITIAL PUBLIC OFFERING
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)		180%
Stock price trigger for redemption of public warrants (in dollars per share)		$ 10
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 | Public Warrants | Class A ordinary shares
INITIAL PUBLIC OFFERING
Redemption of warrants per share		$ 10
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00
INITIAL PUBLIC OFFERING
Minimum threshold written notice period for redemption of public warrants		30 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00 | Public Warrants
INITIAL PUBLIC OFFERING
Redemption price per public warrant (in dollars per share)		$ 0.10
Threshold maximum period for filing registration statement after business combination		30 days
Threshold number of trading days before sending notice of redemption to warrant holders		3 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00 | Public Warrants | Class A ordinary shares
INITIAL PUBLIC OFFERING
Stock price trigger for redemption of public warrants (in dollars per share)		$ 10
Trading period after business combination used to measure dilution of warrant		20 days
Initial Public Offering
INITIAL PUBLIC OFFERING
Number of units sold	23,000,000
Number of warrants in a unit	0.5
Share price	$ 10	$ 10.30
Initial Public Offering | Class A ordinary shares
INITIAL PUBLIC OFFERING
Purchase price, per unit	$ 11.50
Number of shares in a unit	1
Number of shares issuable per warrant	1
Initial Public Offering | Public Warrants
INITIAL PUBLIC OFFERING
Number of units sold	23,000,000
Number of shares in a unit	1
Number of warrants in a unit	0.5
Over-allotment option
INITIAL PUBLIC OFFERING
Number of units sold	3,000,000
Over-allotment option | Public Warrants
INITIAL PUBLIC OFFERING
Number of units sold	3,000,000
Purchase price, per unit	$ 10

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		3 Months Ended	9 Months Ended
	Jan. 07, 2022	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
PRIVATE PLACEMENT
Aggregate purchase price				$ 15,900,000
Fair value of warrant	$ 0.51
Aggregate fair value of warrants	$ 7,791,000	$ 981,000	$ (548,000)	$ (9,546,000)
Class A ordinary shares
PRIVATE PLACEMENT
Number of shares per warrant	1
Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	15,900,000
Price of warrants	$ 1
Private Placement Warrants | Redemption Of Warrant Price Per Share Equals Or Exceeds10.00
PRIVATE PLACEMENT
Stock price trigger for redemption of public warrants (in dollars per share)			$ 10
Private Placement Warrants | Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $10.00 and is Less Than $18.00
PRIVATE PLACEMENT
Stock price trigger for redemption of public warrants (in dollars per share)			$ 18
Over-allotment option | Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	1,500,000
Private Placement | Private Placement Warrants
PRIVATE PLACEMENT
Number of warrants to purchase shares issued	15,900,000
Price of warrants	$ 1
Aggregate purchase price	$ 15,900,000
Private Placement | Private Placement Warrants | Class A ordinary shares
PRIVATE PLACEMENT
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)						9 Months Ended
	May 23, 2023 $ / shares shares	Jan. 07, 2022	Oct. 29, 2021 USD ($) shares	Apr. 24, 2021 USD ($) shares	Feb. 09, 2021 USD ($) shares	Sep. 30, 2023 Y $ / shares shares	Jun. 29, 2023 $ / shares	Dec. 31, 2022 $ / shares shares	Oct. 31, 2021 shares
Common Class B
RELATED PARTY TRANSACTIONS
Shares outstanding (in shares)						1,000,000		5,750,000
Common stock, par value per share | $ / shares						$ 0.0001	$ 0.0001	$ 0.0001
Namaste | Purchase Agreement | Common Class B
RELATED PARTY TRANSACTIONS
Number of shares to be issued in relating to acquisition of membership interests	3,490,949
Common stock, par value per share | $ / shares	$ 0.0001
Namaste | Purchase Agreement | Private Placement Warrants
RELATED PARTY TRANSACTIONS
Number of warrants to be issued in relating to acquisition of membership interests	15,900,000
Founder Shares | Sponsor
RELATED PARTY TRANSACTIONS
Sponsor granted				300,000	1,078,125
Fair value of founder shares | $			$ 225	$ 900	$ 3,234
Number of shares transferred (in shares)			75,000
Founder Shares | Sponsor | Common Class B
RELATED PARTY TRANSACTIONS
Number of shares issued					7,187,500
Aggregate purchase price | $					$ 25,000
Number of shares transferred (in shares)				75,000
Aggregate number of shares owned				6,887,500
Number of shares surrendered									1,437,500
Shares outstanding (in shares)									5,750,000
Shares subject to forfeiture						750,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders		20%
Restrictions on transfer period of time after Business Combination completion						1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial Business Combination (in dollars per share) | $ / shares						$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial Business Combination						20 days
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial Business Combination						30 days
Threshold period after the Business Combination in which the 20 trading days within any 30 trading day period commences						150 days
Vesting period | Y						8
Founder Shares | Sponsor | Common Class B | Upon the completion of an initial Business Combination
RELATED PARTY TRANSACTIONS
Vesting percentage						50%
Founder Shares | Sponsor | Common Class B | Upon attainment and maintenance of certain shareholder return targets based on share trading prices and any dividends paid
RELATED PARTY TRANSACTIONS
Vesting percentage						25%
Founder Shares | Namaste | Private Placement Warrants
RELATED PARTY TRANSACTIONS
Number of warrants to be issued in relating to acquisition of membership interests	15,900,000
Founder Shares | Namaste | Purchase Agreement | Common Class B
RELATED PARTY TRANSACTIONS
Number of shares to be issued in relating to acquisition of membership interests	3,490,949
Common stock, par value per share | $ / shares	$ 0.0001

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)				1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 26, 2023	May 23, 2023	Jan. 04, 2022	Jan. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Nov. 08, 2023	Sep. 26, 2023	Aug. 31, 2023	Dec. 31, 2022	Sep. 20, 2021	Feb. 09, 2021
RELATED PARTY TRANSACTIONS
Repayment of promissory note - related party								$ 244,225
Expenses paid					$ 261,062	$ 437,753	$ 1,411,359	1,807,183
Anchor investors
RELATED PARTY TRANSACTIONS
Number of shares issued							1,980,000
Aggregate purchased unit as percentage							9.90%
Purchase price, per unit					$ 10		$ 10
Aggregate purchase price							$ 19,800,000
Class A ordinary shares
RELATED PARTY TRANSACTIONS
Common stock, par value per share					$ 0.0001		$ 0.0001					$ 0.0001
Promissory Note with Related Party
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note													$ 350,000	$ 300,000
Repayment of promissory note - related party								244,225
Additional borrowing capacity					$ 0		$ 0					$ 0
Administrative support agreement | Sponsor
RELATED PARTY TRANSACTIONS
Amount of transaction			$ 930,000
Period of agreement			18 months
Payments			$ 601,167
Payments for bonuses			549,000
Payments for administrative support expenses				$ 51,667
Notice for completion of Business Combination or Liquidation							30 days
Expenses incurred					50,000	155,000	$ 50,000	776,500
Expenses paid					270,333	$ 155,000	270,333	$ 1,014,500
Administrative support agreement | Mr.Goel | Sponsor
RELATED PARTY TRANSACTIONS
Annual salary		$ 312,000	312,000
Expenses per month for office space, utilities and research, analytical, secretarial and administrative support		9,000
Administrative support agreement | Mr. Coad | Sponsor
RELATED PARTY TRANSACTIONS
Annual salary			200,000
Expenses per month for office space, utilities and research, analytical, secretarial and administrative support			$ 9,000
Administrative support agreement | Chief Operating Officer and Chief Financial Officer | Sponsor
RELATED PARTY TRANSACTIONS
Annual salary		200,000
Payments		16,666.67
Payments for bonuses		$ 150,000
Non redemption agreements | Class A ordinary shares | Holders
RELATED PARTY TRANSACTIONS
Number of shares held by the holders agreed to not to request redemption or reverse any previously submitted redemption demand	3,850,000
Common stock, par value per share	$ 0.0001
Number of shares agreed to issue	962,500
Estimated amount of fair value of shares agreed	$ 158,139
Price per share fair value	$ 0.1643
Working Capital Loans
RELATED PARTY TRANSACTIONS
Accrued amount					0		0					$ 0
Working Capital Loans | Working capital loans warrant
RELATED PARTY TRANSACTIONS
Promissory note aggregate					$ 2,000,000		$ 2,000,000
Conversion price					$ 1		$ 1
Second Promissory Note | Sponsor
RELATED PARTY TRANSACTIONS
Maximum borrowing capacity of related party promissory note					$ 200,000		$ 200,000		$ 50,000
Aggregate principal amount											$ 300,000
Company borrowed					100,000		100,000			$ 100,000
Outstanding borrowings under the working capital loans					$ 100,000		$ 100,000			$ 100,000

COMMITMENTS & CONTINGENCIES (De

COMMITMENTS & CONTINGENCIES (Details)					3 Months Ended	9 Months Ended
	Jun. 13, 2023 USD ($) $ / shares shares	Apr. 14, 2023 USD ($)	Feb. 07, 2022	Jan. 07, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Sep. 30, 2023 USD ($) item $ / shares shares	Dec. 31, 2022 USD ($)
COMMITMENTS & CONTINGENCIES
Number of demands for registration of securities | item						3
Underwriting cash discount, in dollars per Unit | $ / shares				$ 0.20
Underwriter cash discount				$ 4,600,000
Deferred underwriting fee in dollars per Unit | $ / shares						$ 0.35
Deferred underwriting fee payable		$ 8,050,000					$ 8,050,000
Aggregate deferred underwriting fee payable						$ 8,050,000
Other income attributable to derecognition of deferred underwriting fee allocated to offering costs		214,220				$ 214,220
Waiver of deferred underwriting discount		$ 7,835,780			$ 7,835,780
Forward purchase agreement
COMMITMENTS & CONTINGENCIES
Number of shares agreed to subscribe | shares						3,000,000
Common shares, par value (in dollars per share) | $ / shares						$ 10
Value of shares agreed to subscribe						$ 30,000,000
Service Provider Agreement
COMMITMENTS & CONTINGENCIES
Fees payable included in accrued expenses						100,000
Service Provider Agreement | Sponsor
COMMITMENTS & CONTINGENCIES
Amount due and payable to service provider	$ 100,000
Additional cash payment to be made	$ 100,000
Number of Founder Shares agreed to issue | shares	50,000
Price per share | $ / shares	$ 0.003
Aggregate fair value of Founder Shares agreed to issue					$ 8,215
Aggregate fair value of Founder Shares (in dollars per share) | $ / shares					$ 0.1643
Over-allotment option
COMMITMENTS & CONTINGENCIES
Underwriting option period			45 days
Sale of units, net of underwriting discounts (in shares) | shares				3,000,000
Aggregate underwriter cash discount				$ 600,000
Deferred underwriting fee payable						$ 1,050,000

SHAREHOLDERS' DEFICIT - Prefere

SHAREHOLDERS' DEFICIT - Preference Shares (Details) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
SHAREHOLDERS' DEFICIT
Preference shares, shares authorized	1,000,000	1,000,000
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares issued	0	0
Preference shares, shares outstanding	0	0

SHAREHOLDERS' DEFICIT - Ordinar

SHAREHOLDERS' DEFICIT - Ordinary Shares (Details)	9 Months Ended
	Sep. 30, 2023 Vote $ / shares shares	Jun. 29, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares
Sponsor
SHAREHOLDERS' DEFICIT
Threshold conversion ratio of stock	1
Class A ordinary shares
SHAREHOLDERS' DEFICIT
Common shares, shares authorized (in shares)	300,000,000		300,000,000
Common stock, par value per share | $ / shares	$ 0.0001		$ 0.0001
Common shares, votes per share | Vote	1
Common shares, shares issued (in shares)	8,964,415
Common shares, shares outstanding	8,964,415
Number of common stock issuable pursuant to Initial Business Combination, as a percent of outstanding shares	20%
Class A ordinary shares | Sponsor
SHAREHOLDERS' DEFICIT
Common shares, shares issued (in shares)		4,750,000
Class A ordinary shares subject to possible redemption
SHAREHOLDERS' DEFICIT
Number of shares held by the shareholders exercised their right to redeem such shares.	18,785,585
Temporary equity, shares outstanding	4,214,415		23,000,000
Class A ordinary shares not subject to possible redemption
SHAREHOLDERS' DEFICIT
Common shares, shares issued (in shares)	4,750,000		0
Common shares, shares outstanding	4,750,000		0
Class B ordinary shares
SHAREHOLDERS' DEFICIT
Common shares, shares authorized (in shares)	30,000,000		30,000,000
Common stock, par value per share | $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share | Vote	1
Common shares, shares issued (in shares)	1,000,000		5,750,000
Common shares, shares outstanding	1,000,000		5,750,000
Threshold conversion ratio of stock	1

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Assets:
Cash and Marketable securities held in Trust Account	$ 45,697,836	$ 240,113,631
Liabilities:
Warrant liabilities	1,529,000	2,077,000
Marketable securities held in Trust Account
FAIR VALUE MEASUREMENTS
Carrying Value/Amortized Cost	45,697,836	240,113,631
Gross Unrealized Gain	0	0
Gross Unrealized Losses		(6,094)
Fair Value	45,697,836	240,107,374
Level 1
Assets:
Cash and Marketable securities held in Trust Account	45,697,836	240,113,631
Level 1 | Public Warrants
Liabilities:
Warrant liabilities	575,000	805,000
Level 3 | Private Placement Warrants
Liabilities:
Warrant liabilities	$ 954,000	$ 1,272,000

FAIR VALUE MEASUREMENTS - Fair

FAIR VALUE MEASUREMENTS - Fair Value Measurements Inputs (Details) - Level 1	Sep. 30, 2023 item $ / shares	Dec. 31, 2022 item $ / shares	Jan. 07, 2022 item $ / shares
Risk-free interest rate | Public Warrants
FAIR VALUE MEASUREMENTS
Measurement input			0.0164
Risk-free interest rate | Private Placement Warrants
FAIR VALUE MEASUREMENTS
Measurement input	0.0460	0.0399
Expected term (years) | Public Warrants
FAIR VALUE MEASUREMENTS
Measurement input			6.50
Expected term (years) | Private Placement Warrants
FAIR VALUE MEASUREMENTS
Measurement input	5.52	5.51
Expected volatility | Public Warrants
FAIR VALUE MEASUREMENTS
Measurement input			0.072
Expected volatility | Private Placement Warrants
FAIR VALUE MEASUREMENTS
Measurement input	0.323	0.254
Exercise price | Public Warrants
FAIR VALUE MEASUREMENTS
Measurement input | $ / shares			11.50
Exercise price | Private Placement Warrants
FAIR VALUE MEASUREMENTS
Measurement input | $ / shares	11.50	11.50
Stock price of Class A ordinary share | Public Warrants
FAIR VALUE MEASUREMENTS
Measurement input | $ / shares			9.83
Stock price of Class A ordinary share | Private Placement Warrants
FAIR VALUE MEASUREMENTS
Measurement input | $ / shares	10.77	10.37

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Changes in the fair value of the Company's level 3 financial instruments (Details) - Level 3 - Private Placement Warrants - USD ($)	3 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023
FAIR VALUE MEASUREMENTS
Fair value at beginning of period	$ 954,000	$ 1,272,000	$ 1,272,000
Change in fair value	0	(318,000)	0
Fair value at end of period	$ 954,000	$ 954,000	$ 1,272,000

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)		9 Months Ended
	Jan. 07, 2022	Sep. 30, 2023	Dec. 31, 2022
U.S. Treasury Securities
FAIR VALUE MEASUREMENTS
Cash held in the Trust Account		$ 0	$ 163
Common Class A
FAIR VALUE MEASUREMENTS
Number of shares in a unit		1
Public Warrants
FAIR VALUE MEASUREMENTS
Initial measurement at January 7, 2022	$ 5,865,000
Price per share (in dollars per share)	$ 0.51	$ 0.05	$ 0.07
Aggregate fair value		$ 575,000	$ 805,000
Number of warrants in a unit		0.5
Private Placement Warrants
FAIR VALUE MEASUREMENTS
Initial measurement at January 7, 2022	$ 8,109,000
Price per share (in dollars per share)	$ 0.51	$ 0.06	$ 0.08
Aggregate fair value		$ 954,000	$ 1,272,000